Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using a Modified ALCL99 Regimen for Chinese Children With Newly Diagnosed High-risk Anapestic Large Cell Lymphoma

NCT04881838 is registered in ClinicalTrials.gov with Children's Cancer Group, China as lead sponsor.

NCT NCT04881838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04881838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using a Modified ALCL99 Regimen for Chinese Children With Newly Diagnosed High-risk Anapestic Large Cell Lymphoma
Lead sponsor
Children's Cancer Group, China
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 1, 2021
Completion date
March 1, 2029
Enrollment
172 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediatric anaplastic large cell lymphoma